Can a Polyphenol-Rich Diet Slow Biological Aging? An 18-Month Trial

Why This Study Matters

Most research on olive polyphenols and aging looks at outcomes like cardiovascular disease or metabolic syndrome -- endpoints that take decades to develop and are influenced by dozens of confounding factors. DNA methylation clocks offer something different: a molecular readout of biological age that can shift measurably in months, not years.

This trial asked whether a polyphenol-rich dietary pattern -- built on a Mediterranean diet and amplified with green tea, walnuts, and a high-polyphenol aquatic plant called Mankai -- could slow biological aging as measured by seven validated epigenetic clocks. The study didn't isolate a single compound. Instead, it tested escalating doses of dietary polyphenols (from ~440 mg/day up to ~1,200 mg/day) within a controlled dietary framework and tracked the effect on DNA methylation over 18 months.

What makes it especially relevant for olive polyphenol research: when the investigators looked at which specific urinary polyphenol metabolites were associated with the greatest reduction in methylation age, hydroxytyrosol was among them.

How It Was Designed

The DIRECT PLUS trial was a large, 18-month randomized controlled trial conducted at the Nuclear Research Center Negev in Israel. 256 participants with abdominal obesity or dyslipidemia were randomized to one of three groups:

• Group 1 (control): Healthy dietary guidelines
• Group 2 (MED): Mediterranean diet + 28 g walnuts/day (~440 mg/day added polyphenols)
• Group 3 (Green-MED): Mediterranean diet + walnuts + 3-4 cups green tea/day + 500 mL Mankai shake/day (~800 mg/day added polyphenols)

Biological age was assessed using the Illumina EPIC methylation array -- the current gold standard for epigenomic profiling -- and calculated across seven independent epigenetic clocks: Horvath (2013), Hannum (2013), Li (2018), Horvath Skin and Blood (2018), PhenoAge (2018), PCGrimAge (2022), and DunedinPACE. Each clock uses a different set of DNA methylation sites to estimate biological age, so agreement across multiple clocks strengthens any finding.

The trial was pre-registered on ClinicalTrials.gov (NCT03020186) before enrollment began. Polyphenol intake wasn't just self-reported -- the researchers verified it by measuring urinary polyphenol metabolites, including hydroxytyrosol, tyrosol, and urolithin compounds.

What They Found

Greater adherence to the Green-MED diet was significantly associated with a lower 18-month change in methylation age on the Li and Hannum clocks:

Epigenetic Clock	Green-MED Adherence Effect (beta)	p-value	What It Measures
Li mAge	-0.41 (favorable)	0.004	Multi-tissue epigenetic age
Hannum mAge	-0.38 (favorable)	0.03	Blood-based epigenetic age
Horvath mAge	No significant association	NS	Pan-tissue epigenetic age
PhenoAge	No significant association	NS	Mortality-linked epigenetic age
PCGrimAge	No significant association	NS	Composite mortality predictor
DunedinPACE	No significant association	NS	Pace of aging

Green indicates a statistically significant favorable association with Green-MED diet adherence. NS = not significant. Beta values represent the standardized effect of diet adherence on relative change in methylation age over 18 months.

The headline number: participants in the highest polyphenol group showed an approximately 8.9-month favorable difference between their observed and expected methylation age over the 18-month trial (p = 0.02). In plain terms, their cells aged roughly 8.9 months less than their chronological age would have predicted.

Reading the Results

The polyphenol dose-response pattern. The study's three groups created an escalating polyphenol gradient: control, moderate (~440 mg/day added), and high (~1,200 mg/day total). The biological age attenuation tracked this gradient -- the highest polyphenol group showed the strongest effect. That dose-response relationship is one of the hallmarks researchers look for when evaluating whether a dietary factor is likely causal rather than coincidental.

Specific polyphenol metabolites linked to age attenuation. The researchers didn't stop at group-level comparisons. They measured individual urinary polyphenol metabolites and tested which ones were statistically associated with reductions in Li methylation age. Three stood out: hydroxytyrosol, tyrosol, and urolithin C (all p < 0.05). Hydroxytyrosol and tyrosol are the signature metabolites of olive polyphenols. Urolithin C comes from the gut metabolism of ellagitannins found in walnuts. This suggests that the biological age effect wasn't driven by a single food or compound -- it reflected the combined action of multiple polyphenol classes, with olive-derived metabolites playing a measurable role.

Why two clocks moved and five didn't. The Li and Hannum clocks showed significant associations; the Horvath, PhenoAge, PCGrimAge, Horvath Skin and Blood, and DunedinPACE clocks did not. This isn't a failure -- different clocks measure different facets of biological aging. Li and Hannum are trained on chronological age prediction from blood DNA methylation, making them sensitive to systemic dietary changes that affect blood cell composition and turnover. The other clocks are calibrated to different endpoints (mortality, multi-tissue aging, pace of aging), which may require longer interventions or different mechanisms to shift.

What Didn't Change

Five of the seven epigenetic clocks showed no significant association with Green-MED diet adherence. The study did not find significant differences between the standard Mediterranean diet group and the control group on methylation age -- the effect was specific to the highest-polyphenol Green-MED pattern. This is a useful constraint: it suggests that a moderate polyphenol boost from walnuts alone wasn't sufficient, and that the additional polyphenols from green tea and Mankai were necessary to reach a threshold for epigenetic impact.

Broader Context

DNA methylation clocks are among the most promising biomarkers in aging research. Developed by Steve Horvath and others beginning in 2013, they've been validated against all-cause mortality, disease incidence, and cognitive decline in large cohort studies. But most methylation clock research is observational -- tracking how fast people age rather than testing whether an intervention can slow it down.

This trial is one of a small number of randomized controlled studies to show that a dietary intervention can attenuate epigenetic aging. The PREDIMED trial previously demonstrated cardiovascular benefits from extra virgin olive oil rich in polyphenols, and the 2011 EFSA health claim authorized the connection between olive oil polyphenols and the protection of blood lipids from oxidative damage. The Meir 2023 study extends that evidence into a different domain -- suggesting that the polyphenol compounds found in olive oil, green tea, and other plant foods may influence not just disease risk markers but the underlying biology of aging itself.

It's worth being precise about what this study does and doesn't show. It demonstrates that a high-polyphenol Mediterranean dietary pattern can slow DNA methylation-assessed aging, and that urinary hydroxytyrosol levels specifically track with that effect. It does not demonstrate that hydroxytyrosol alone causes the effect -- this was a multi-component dietary intervention, and the polyphenol sources included green tea catechins, walnut ellagitannins, and Mankai compounds alongside olive-derived polyphenols.

Related Research

Continue exploring olive oil and polyphenol science:

• Hydroxytyrosol Improves 7 Biomarkers of Aging and Inflammation
• Higher Polyphenol Levels Linked to 29% Lower Inflammation
• Olive Oil Phenolics Reduced Postprandial LDL Oxidation in Humans

Source: View the original study on PubMed

Olivea's Dosage

This trial used a dietary pattern delivering approximately 1,200 mg/day of total polyphenols in the highest group, drawn from multiple plant sources. Olive polyphenols were one component of that pattern -- and hydroxytyrosol was one of the specific metabolites associated with reduced biological age. Each Olivea capsule delivers over 20 mg of hydroxytyrosol per serving. Our most recent third-party certificate of analysis confirmed 23.5 mg per capsule.

We share this research for transparency. This is an independent study -- we did not fund it, design it, or conduct it.

Editorial Information

Research note. This article summarizes third-party research published in a peer-reviewed journal. Olivea did not conduct or fund the study. Findings reflect the cited paper only and do not establish efficacy of Olivea products.

.